Access this article
We’re sorry, something doesn't seem to be working properly.
Please try refreshing the page. If that doesn't work, please contact support so we can address the problem.
References
Hayano K, Ohira G, Hirata A, et al. Imaging biomarkers for the treatment of esophageal cancer. World J Gastroenterol. 2019;25(24):3021–9. https://doi.org/10.3748/wjg.v25.i24.3021
Ganeshan B, Miles KA. Quantifying tumour heterogeneity with CT. Cancer Imaging. 2013;13(1):140–9. https://doi.org/10.1102/1470-7330.2013.0015
Hirata A, Hayano K, Ohira G, et al. Volumetric histogram analysis of apparent diffusion coefficient as a biomarker to predict survival of esophageal cancer patients. Ann Surg Oncol. (in press).
Hirata A, Hayano K, Ohira G, et al. Volumetric histogram analysis of apparent diffusion coefficient for predicting pathological complete response and survival in esophageal cancer patients treated with chemoradiotherapy. Am J Surg. 2019; https://doi.org/10.1016/j.amjsurg.2019.07.040
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Disclosures
Koichi Hayano, Atsushi Hirata, and Hisahiro Matsubara declare no conflicts of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
About this article
Cite this article
Hayano, K., Hirata, A. & Matsubara, H. ASO Author Reflections: MRI-Derived Biomarker to Select Optimal Treatment for Esophageal Cancer Patients. Ann Surg Oncol 27, 3090–3091 (2020). https://doi.org/10.1245/s10434-020-08298-9
Received:
Published:
Issue Date:
DOI: https://doi.org/10.1245/s10434-020-08298-9